Your Partners for Drug and Medical Device Development
European Focus – International Coverage
Venn Life Sciences is an Integrated Drug Development Partner offering a unique combination of drug and device development expertise and clinical trial design and management. This enables us to create, plan and execute drug and medical device development programs effectively and seamlessly for our clients.
“We have been delighted to work with Venn Life Sciences on this complex clinical trial. Their commitment to quality coupled with an in-depth knowledge of running Investigator Initiated Studies has facilitated the effective and efficient management of the various activities and requirements associated with the study. We fully expect that together we will bring the trial to completion on time and on budget.”
Professor Keith G. Oldroyd, Director of Research and Development West of Scotland Regional Heart & Lung Centre, Golden Jubilee National Hospital
[responsive]<img class="aligncenter size-full wp-image-4536" src="https://www.vennlifesciences.com/wp-content/uploads/2017/07/Training-Slide-Banner.jpg" alt="" width="1680" height="345" />[/responsive] [gap height="10"]Pharmacokinetics (PK) is generally referred to as ‘what the body does to the drug’ versus ‘what the drug does to the
Pharmacokinetics (PK) is generally referred to as ‘what the body does to the drug’ versus ‘what the drug does to the body’ (pharmacodynamics [PD]). Pharmacokinetics describes the fate, or time course, of an administered drug within the body. The physiological processes that determine the time course of the drug are Absorption, Distribution, Metabolism and Elimination (ADME). Both the desired effects and undesired effects of a drug are related to the drug levels in the body. The pharmacokinetic properties of a drug determine these levels. Ultimately, the optimal dose and dosing regimen to reach the desired or therapeutic drug levels are determined by means of pharmacokinetics.
This course will focus on the physiochemical properties underlying the pharmacokinetics of a drug, will give insight in the calculation and interpretation of the pharmacokinetic parameters and will also explain the importance and application of pharmacokinetics in preclinical and clinical drug development.
<span style=”color: #333333;”><strong>Who should attend?</strong></span> You are interested in pharmacokinetics (or toxicokinetics), either because you started a career in drug development or in pharmacokinetics, you regularly interact with others working in pharmacokinetics, or simply because you want to broaden your knowledge on this topic.
<span style=”color: #333333;”><strong>Costs</strong></span> The costs of this course will be € 1,850.- (excl. VAT) for three days. For attendees from universities, academic institutions or governmental authorities there will be a reduced fee of €950.00 – (excl. VAT).
<span style=”color: #333333;”><strong>Timing & Location</strong></span> This course consists of three days and is scheduled on the 24, 25 and 26 April 2019 at Venn Life Sciences, Breda, The Netherlands. The maximum desired limit is 25 participants.
<span style=”color: #333333;”><strong>Information & Registration</strong></span> For more information, <span style=”text-decoration: underline;”><strong><a href=”mailto:Peggy.IJzelman@vennlife.com?subject=Course Information Request”>contact us</a></strong></span>. For registration, <span style=”text-decoration: underline;”><strong><a href=”https://www.vennlifesciences.com/training-registration-form/” rel=”noopener”>click here</a></strong></span>.
<div style=”color: #333; font-size: 15px; text-align: center;”>For more information on this training course – Why Pharmacokinetics? : <span style=”text-decoration: underline;”><strong><a href=”https://www.vennlifesciences.com/news/training-courses/course-pharmacokinetics/”>Click here</a></strong></span></div>
<span style=”color: #333333;”><strong>We look forward to seeing you there!</strong></span>